← European Medicine Shortage Tracker · all medicines

Butizide + potassio canrenoato shortage — availability across Europe

Butizide + potassio canrenoato currently has availability issues reported in 1 European register: Italy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Shortage  ATC — · also listed as: BUTIZIDE + POTASSIO CANRENOATO · data refreshed 7 August 2026

Key facts

As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Butizide + potassio canrenoato, covering 1 affected product presentation. The longest-running open report was filed in Italy on 2026-05-18 and has now been open for about 3 months. Where agencies state a cause, manufacturing problems lead with 1 of the 1 stated-cause reports. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇮🇹 ItalyShortage
KADIUR
2026-05-18Problemi produttivi
Alternatives: AIFA: import of a foreign equivalent can be authorised.
register ↗

Full report history (1 register entry)

Every individual register entry for Butizide + potassio canrenoato in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇮🇹 ITKADIURShortage2026-05-18Problemi produttivi

Frequently asked

Is Butizide + potassio canrenoato currently in shortage in Europe?

Yes. As of 7 August 2026, availability issues are reported in: Italy. Availability is national — a shortage in one country does not mean it is short everywhere.

Are there alternatives to Butizide + potassio canrenoato?

1 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Butizide + potassio canrenoato availability data come from?

Directly from the official medicines-agency register that lists Butizide + potassio canrenoato: AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Butizide + potassio canrenoato — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/butizide-potassio-canrenoato/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Butizide + potassio canrenoato availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/butizide-potassio-canrenoato/">Butizide + potassio canrenoato shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Butizide + potassio canrenoato: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 7 August 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.